What is Tekton Research?
Founded in 2006, Tekton Research operates as a sophisticated clinical research site network that bridges the gap between biopharma sponsors and patient populations. By leveraging a team of seasoned clinical professionals and nationally recognized key opinion leaders, the organization provides comprehensive support for trials ranging from early-stage development to late-stage validation. Their operational model emphasizes scientific rigor, efficient recruitment, and long-term patient retention, making them a critical partner for CROs and pharmaceutical companies aiming to accelerate the delivery of new therapies to market. The company's focus on cardiometabolic and general medicine further cements its role as a vital infrastructure provider in the global medical research ecosystem.
How much funding has Tekton Research raised?
Tekton Research has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Tekton Research
PPP
Public-Private Partnership
What's next for Tekton Research?
With this late-stage funding, Tekton Research is well-positioned to expand its footprint and enhance its technological capabilities in trial management. The strategic allocation of these resources will likely focus on optimizing site performance and deepening partnerships with global biopharma entities. As the clinical research industry faces increasing pressure to shorten development timelines, Tekton's commitment to patient-centered care and operational excellence provides a competitive advantage. Future growth will likely involve scaling their network to accommodate more complex, multi-site trials, ensuring that they remain at the forefront of therapeutic innovation and clinical trial efficiency.
See full Tekton Research company page
